【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 9
1.2 List of Figures 10
2 Introduction 11
2.1 Catalyst 11
2.2 Related Reports 12
2.3 About PharmaSphere Report Series 13
3 A Changing and Challenging Deal Making Landscape 14
3.1 Overview 14
3.2 Deal Drivers 15
3.2.1 The Patent Cliff 15
3.2.2 Deal-Adverse Environment 18
3.2.3 Spike in Regulatory Approvals but Innovation Gap Continues 22
3.2.4 FDA’s Proposal to Lower Regulatory Standards in Early-Stage Alzheimer’s Research 23
3.2.5 More Stringent Regulatory Regime in a Post-Vioxx and Avandia World 24
3.2.6 Viewpoint: Vioxx and Avandia Cases 25
4 An Unsustainable R&D Paradigm 27
4.1 Big Pharma’s Embrace of Disruptive Innovation May Fix Broken R&D Model 28
4.1.1 Pre-Competitive Information Sharing 28
4.1.2 Open-Source Patient Data 29
4.1.3 ‘Big Data’ and Drug Discovery 30
4.1.4 Tech Transfer in Action: Astellas Pharma Taps IT for Drug Discovery 31
4.1.5 Drug Recycling 31
4.1.6 Viewpoint: Drug Repurposing at NCATS 32
4.1.7 Tech Transfer in Action: Roche & Broad Join to Bring Failed Drugs Back from the Dead 33
5 Major Global Technology Transfer Alliances 34
5.1 The Bayh-Dole Act of 1980 34
5.2 Deals Overview 36
5.3 Biscayne Pharma Enters into Licensing Agreement with University of Miami for Growth Hormone-Releasing Technology 40
5.3.1 Deal Summary 40
5.3.2 Deal Analysis 40
5.4 Genoa Pharma Enters into Research Agreement with McMaster University for IPF 42
5.4.1 Deal Summary 42
5.4.2 Deal Analysis 42
5.5 AstraZeneca Partners with Vanderbilt University for Neuroscience Drug Discovery 44
5.5.1 Deal Summary 44
5.5.2 Deal Analysis 44
5.6 Trovagene Grants License for NPM1 Marker for AML to Duke University 45
5.6.1 Deal Summary 45
5.6.2 Deal Analysis 45
5.7 Synthetic Biologics and University of Texas Ink Research Deal to Fight Pertussis 47
5.7.1 Deal Summary 47
5.7.2 Deal Analysis 47
5.8 BMS and Vanderbilt University Sign Deal to Develop Drugs for Parkinson’s 49
5.8.1 Deal Summary 49
5.8.2 Deal Analysis 49
5.9 AstraZeneca and Broad Institute Partner to Advance Discovery of Antibacterial and Antiviral Agents 50
5.9.1 Deal Summary 50
5.9.2 Deal Analysis 50
5.10 Bayer HealthCare Opens New Lab Space – The CoLaborator – for Biotech Startups 51
5.10.1 Deal Summary 51
5.10.2 Deal Analysis 51
5.11 Novartis Enters into Licensing Agreement with Penn for CART-19 53
5.11.1 Deal Summary 53
5.11.2 Deal Analysis 53
5.12 Sanofi and BWH Agree to Develop Antibodies for Type 1 Diabetes 55
5.12.1 Deal Summary 55
5.12.2 Deal Analysis 55
5.13 AstraZeneca and Leading Academic Organizations Collaborate on Alzheimer’s Research 56
5.13.1 Deal Summary 56
5.13.2 Deal Analysis 56
5.14 Novo Nordisk Enters into R&D Agreement with JDRF for Type 1 Diabetes 57
5.14.1 Deal Summary 57
5.14.2 Deal Analysis 57
5.15 Large Pharmas Unite with the Genome Institute of Singapore to Combat Cancer in Asian Populations 58
5.15.1 Deal Summary 58
5.15.2 Deal Analysis 58
5.15.3 Tech Transfer in Action: National University Singapore Startup AyoxxA Biosystems 59
5.16 University of Washington and ‘Big Pharma’ Join Forces to Research Drug Transporters 60
5.16.1 Deal Summary 60
5.16.2 Deal Analysis 60
5.17 Pharma and the University of Dundee Create Consortium on Cell Signaling Research 61
5.17.1 Deal Summary 61
5.17.2 Deal Analysis 61
5.18 Novo Nordisk and Oxford Join to Identify Novel Biomarkers for Rheumatoid Arthritis 62
5.18.1 Deal Summary 62
5.18.2 Deal Analysis 62
5.19 Elan Corporation and University of Cambridge Enter into Joint Venture to Discover New Therapies Targeting Neurodegenerative Disorders 63
5.19.1 Deal Summary 63
5.19.2 Deal Analysis 63
5.20 GSK and Yale Partner to Develop New Drugs Targeting Disease-Causing Proteins 64
5.20.1 Deal Summary 64
5.20.2 Deal Analysis 64
5.21 Big Pharma Companies and Research Institutions Tackle Early-Stage Research TB 65
5.21.1 Deal Summary 65
5.21.2 Deal Analysis 65
5.22 Accuray Signs Collaboration Agreement with University of Heidelberg to Provide Cutting-edge Research in Radiation Oncology 66
5.22.1 Deal Summary 66
5.22.2 Deal Analysis 66
5.23 UCB and Oxford University Join to Focus on Developing Innovative Medicines for Immunological and Neurological Disorders 67
5.23.1 Deal Summary 67
5.23.2 Deal Analysis 67
5.24 Large Pharma and King’s College London Establish a Center to Tackle Autism 69
5.24.1 Deal Summary 69
5.24.2 Deal Analysis 69
5.25 Merck Establishes an Independent Non-profit Drug Research Institute – the California Institute for Biomedical Research 70
5.25.1 Deal Summary 70
5.25.2 Deal Analysis 70
5.26 J&J and University of Queensland Develop Drugs Using Spider Venom for Treating Pain 71
5.26.1 Deal Summary 71
5.26.2 Deal Analysis 71
5.27 Sanofi and UCSF Form a Pact to Work on New Treatments for Diabetes 73
5.27.1 Deal Summary 73
5.27.2 Deal Analysis 73
5.27.3 Tech Transfer in Action: Tufts University Spin-off Anchor Therapeutics 74
6 Future Outlook 76
7 Appendix 77
7.1 Research Methodology 77
7.1.1 Coverage 77
7.1.2 Secondary Research 77
7.1.3 Expert Panel Validation 78
7.2 About the Author 78
7.2.1 Analyst 78
7.3 Director, Healthcare Industry Dynamics 79
7.4 Global Head of Healthcare 79
7.5 About the Industry Dynamics Team 79
7.6 GlobalData 80
7.7 Contact Us 80
7.8 Disclosure Information 80
7.9 Disclaimer 80
【レポート販売概要】
■ タイトル:PharmaSphere: Early-Stage Technology Transfer Collaborations – Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry■ 英文:PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry
■ 発行日:2013年4月30日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160902
■ 調査対象地域:グローバル
- 経皮薬物送達(Transdermal Drug Delivery)市場及びパイプラインインサイトTransdermal drug delivery system, over the past decades, has emerged as a major tool for treating diseases of the skin. The major underlying factor driving this method is that the human skin is the most readily accessible surface for the delivery of drugs. A transdermal patch is defined as a medicated adhesive patch which is placed on the skin for delivering a specific dose of medication through t …
- Biomet, Inc.:市場シェア分析Biomet, Inc. Market Share Analysis Summary GlobalData’s new report, “Biomet, Inc. Market Share Analysis” provides in-depth information on Biomet, Inc.’s market position in the different medical equipment markets it operates in. The report provides Biomet, Inc. market share information in 10 key market categories – Other Joint Reconstruction, Knee Reconstruction, Cranio Maxillofacial Fixation (CMF) …
- 麻ベース食品の世界市場2016-2020About Hemp Hemp is a sustainable crop, which is seeded toward the end of May or during early June. The hemp plants are grown close together and possess large and broad leaves. The harvesting of hemp begins around 120 days after seeding. Scientists believe that humans have been cultivating hemp for over ten thousand years, owing to its nutritional, medicinal, and industrial properties. As a crop, h …
- Mobile Social Commerce: Social Media + Mobile Commerce Creates Market OpportunitiesThe combination of two powerful industry trends, social networking and mobile commerce, merge to become an even more powerful force that is expected to impact the industry for many years to come. While both mobile commerce and social media are in the early stages of service maturation, the two solutions are starting to come together at a time when they can both propel each other to new heights. So …
- KenyaのCarpets and Other Textile Floor Coverings市場:貿易(輸入、輸出)動向This market research report examines the foreign trade of Kenya and its perspectives on the global market for Carpets and other textile floor сoverings. The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on Carpets and other textile floor сoverings export/import operations …
- 二酸化チタンの世界市場予測(~2021):塗料、製紙、プラスチック、化粧品、インク用途The global titanium dioxide market is projected to grow from USD 10.64 Billion in 2016 to USD 14.12 Billion by 2021, at a CAGR of 5.8% between 2016 and 2021. The increase in per capita consumption of pigments in emerging economies and increasing demand for titanium dioxide from construction and automobile industries are expected to fuel the growth of the global titanium dioxide market during the f …
- 日本脳炎:グローバル臨床試験動向(2014年上半期)Japanese encephalitis Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Japanese encephalitis Global Clinical Trials Review, H1, 2014" provides data on the Japanese encephalitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Japanese encephalitis It includes an overview of the trial numbers and thei …
- 米州のスマートマシン市場:エキスパートシステム、自律ロボット、デジタルアシスタントAbout the Smart Machines Market in the Americas Smart machines have cognitive computing ability, and use artificial intelligence (AI) and machine learning algorithms to sense, learn, reason, and interact with humans. They offer desired output and solve problems accurately and precisely. The rising concept of Industry 4.0 that include automation, IoT, cloud computing, and smart machines in the auto …
- 機能性食品の世界市場分析:製品別(カロテノイド、食物繊維、脂肪酸、鉱物、プレバイオティクス・プロビオティック、ビタミン)、用途別、エンドユーザー別(スポーツ栄養、体重管理、免疫、消化器の健康)、セグメント予測、2014 – 2024The global functional foods market is expected to reach USD 255.10 billion by 2024, according to a new report by Grand View Research, Inc. Growing geriatric population, healthcare costs, consumers ‘consciousness towards their well-being, and changing lifestyle is expected to drive the functional foods market growth over the forecast period. These foods have the ability to combat various diseases p …
- 勃起不全(ED)薬の世界市場2019-2023About this market The high prevalence of conditions resulting in ED is one of the key factors expected to trigger the market’s growth in the forthcoming years. Various health conditions including diabetes, hypertension, obesity, depression, stress, and excessive alcohol consumption are resulting in the rising incidences of ED among elderly as well as young people. As these conditions directly alte …
- 治療薬物モニタリングの世界市場2015During the next decade, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlyi …
- 世界の結晶果糖市場2015The 2015 Deep Research Report on Global Crystalline Fructose Industry is a professional and in-depth study on the current state of the Crystalline Fructose industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Crystalline Fructose market analysis is provided for the international markets including devel …
- スマートセンサーの世界市場:温度センサー、湿度センサー、圧力センサー、流量センサー、タッチセンサー、画像センサー、モーションセンサー、人感センサー、水センサー、位置センサー、光センサー、超音波センサーThe smart sensor market is expected to grow from USD 18.58 Billion in 2015 to USD 57.77 Billion by 2022, at a CAGR of 18.1% between 2016 and 2022. The smart sensor market size, in terms of unit shipments, is estimated to witness double-digit growth rate during the forecast period. The smart sensor is currently witnessing rising demand in the automotive and consumer electronics industries as they a …
- Otto Energy Limited:石油・ガスの開発・生産動向及びコスト分析– 2012Otto Energy Limited Oil & Gas Exploration and Production Operations and Cost Analysis – 2012 Summary Otto Energy Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key …
- 世界の肺炎ワクチン市場動向According to a new research, introduction of the 10-valent pneumococcal conjugate vaccine, PCV10, decreases the rates of clinical pneumonia even in unvaccinated children, a classic example of herd immunity. With a greater number of serotypes in current vaccines, there has been more disease reduction in both vaccinated and unvaccinated populations. As vaccines evolve, similar improvements can be ex …